1. Home
  2. MDWD vs LOGC Comparison

MDWD vs LOGC Comparison

Compare MDWD & LOGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • LOGC
  • Stock Information
  • Founded
  • MDWD 2000
  • LOGC 2010
  • Country
  • MDWD Israel
  • LOGC United States
  • Employees
  • MDWD N/A
  • LOGC N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • LOGC Catalog/Specialty Distribution
  • Sector
  • MDWD Health Care
  • LOGC Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • LOGC Nasdaq
  • Market Cap
  • MDWD 184.8M
  • LOGC 174.3M
  • IPO Year
  • MDWD 2014
  • LOGC 2020
  • Fundamental
  • Price
  • MDWD $19.41
  • LOGC $6.63
  • Analyst Decision
  • MDWD Strong Buy
  • LOGC
  • Analyst Count
  • MDWD 1
  • LOGC 0
  • Target Price
  • MDWD $25.00
  • LOGC N/A
  • AVG Volume (30 Days)
  • MDWD 61.7K
  • LOGC 206.9K
  • Earning Date
  • MDWD 11-26-2024
  • LOGC 03-03-2025
  • Dividend Yield
  • MDWD N/A
  • LOGC N/A
  • EPS Growth
  • MDWD N/A
  • LOGC N/A
  • EPS
  • MDWD N/A
  • LOGC N/A
  • Revenue
  • MDWD $19,720,000.00
  • LOGC $96,000,000.00
  • Revenue This Year
  • MDWD $10.37
  • LOGC N/A
  • Revenue Next Year
  • MDWD $26.36
  • LOGC $422.91
  • P/E Ratio
  • MDWD N/A
  • LOGC N/A
  • Revenue Growth
  • MDWD N/A
  • LOGC N/A
  • 52 Week Low
  • MDWD $11.04
  • LOGC $4.01
  • 52 Week High
  • MDWD $24.00
  • LOGC $8.24
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 57.98
  • LOGC 41.92
  • Support Level
  • MDWD $15.80
  • LOGC $6.29
  • Resistance Level
  • MDWD $18.25
  • LOGC $7.42
  • Average True Range (ATR)
  • MDWD 0.85
  • LOGC 0.31
  • MACD
  • MDWD 0.11
  • LOGC -0.06
  • Stochastic Oscillator
  • MDWD 80.00
  • LOGC 27.56

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About LOGC ContextLogic Inc.

ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives a majority of its revenue from Europe and also has a presence in North America; South America, and other countries.

Share on Social Networks: